Amdocs Statistics
Total Valuation
Amdocs has a market cap or net worth of $9.18 billion. The enterprise value is $9.67 billion.
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025, after market close.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | Sep 30, 2025 |
Share Statistics
Amdocs has 109.99 million shares outstanding. The number of shares has decreased by -2.32% in one year.
| Current Share Class | 109.99M |
| Shares Outstanding | 109.99M |
| Shares Change (YoY) | -2.32% |
| Shares Change (QoQ) | -1.18% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 98.81% |
| Float | 107.73M |
Valuation Ratios
The trailing PE ratio is 17.02 and the forward PE ratio is 11.15. Amdocs's PEG ratio is 1.18.
| PE Ratio | 17.02 |
| Forward PE | 11.15 |
| PS Ratio | 2.02 |
| Forward PS | 1.95 |
| PB Ratio | 2.62 |
| P/TBV Ratio | 19.95 |
| P/FCF Ratio | 14.37 |
| P/OCF Ratio | 12.45 |
| PEG Ratio | 1.18 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 9.74, with an EV/FCF ratio of 15.14.
| EV / Earnings | 17.47 |
| EV / Sales | 2.08 |
| EV / EBITDA | 9.74 |
| EV / EBIT | 12.06 |
| EV / FCF | 15.14 |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.22 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 0.81 |
| Debt / FCF | 1.31 |
| Interest Coverage | 29.64 |
Financial Efficiency
Return on equity (ROE) is 15.73% and return on invested capital (ROIC) is 11.48%.
| Return on Equity (ROE) | 15.73% |
| Return on Assets (ROA) | 7.87% |
| Return on Invested Capital (ROIC) | 11.48% |
| Return on Capital Employed (ROCE) | 16.10% |
| Revenue Per Employee | $159,907 |
| Profits Per Employee | $19,055 |
| Employee Count | 29,058 |
| Asset Turnover | 0.73 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Amdocs has paid $118.07 million in taxes.
| Income Tax | 118.07M |
| Effective Tax Rate | 17.47% |
Stock Price Statistics
The stock price has decreased by -6.95% in the last 52 weeks. The beta is 0.52, so Amdocs's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -6.95% |
| 50-Day Moving Average | 84.07 |
| 200-Day Moving Average | 87.38 |
| Relative Strength Index (RSI) | 51.77 |
| Average Volume (20 Days) | 863,733 |
Short Selling Information
| Short Interest | 5.15M |
| Short Previous Month | 4.58M |
| Short % of Shares Out | 5.69% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.54 |
Income Statement
In the last 12 months, Amdocs had revenue of $4.65 billion and earned $553.71 million in profits. Earnings per share was $4.90.
| Revenue | 4.65B |
| Gross Profit | 1.73B |
| Operating Income | 801.71M |
| Pretax Income | 675.90M |
| Net Income | 553.71M |
| EBITDA | 993.49M |
| EBIT | 801.71M |
| Earnings Per Share (EPS) | $4.90 |
Full Income Statement Balance Sheet
The company has $342.47 million in cash and $838.64 million in debt, giving a net cash position of -$496.17 million or -$4.51 per share.
| Cash & Cash Equivalents | 342.47M |
| Total Debt | 838.64M |
| Net Cash | -496.17M |
| Net Cash Per Share | -$4.51 |
| Equity (Book Value) | 3.55B |
| Book Value Per Share | 31.85 |
| Working Capital | 300.69M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $737.18 million and capital expenditures -$98.55 million, giving a free cash flow of $638.63 million.
| Operating Cash Flow | 737.18M |
| Capital Expenditures | -98.55M |
| Free Cash Flow | 638.63M |
| FCF Per Share | $5.81 |
Full Cash Flow Statement Margins
Gross margin is 37.24%, with operating and profit margins of 17.25% and 11.94%.
| Gross Margin | 37.24% |
| Operating Margin | 17.25% |
| Pretax Margin | 14.55% |
| Profit Margin | 11.94% |
| EBITDA Margin | 21.38% |
| EBIT Margin | 17.25% |
| FCF Margin | 13.74% |
Dividends & Yields
This stock pays an annual dividend of $2.11, which amounts to a dividend yield of 2.53%.
| Dividend Per Share | $2.11 |
| Dividend Yield | 2.53% |
| Dividend Growth (YoY) | 10.04% |
| Years of Dividend Growth | 13 |
| Payout Ratio | 42.02% |
| Buyback Yield | 2.32% |
| Shareholder Yield | 4.85% |
| Earnings Yield | 6.03% |
| FCF Yield | 6.96% |
Dividend Details Analyst Forecast
The average price target for Amdocs is $108.00, which is 29.47% higher than the current price. The consensus rating is "Buy".
| Price Target | $108.00 |
| Price Target Difference | 29.47% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 1.75% |
| EPS Growth Forecast (5Y) | 16.97% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Amdocs has an Altman Z-Score of 4.91 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.91 |
| Piotroski F-Score | 5 |